AHCO logo

AdaptHealth Corp. Stock Price

NasdaqCM:AHCO Community·US$1.3b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 10 Fair Values set on narratives written by author

AHCO Share Price Performance

US$9.66
1.36 (16.39%)
US$11.00
Fair Value
US$9.66
1.36 (16.39%)
12.2% undervalued intrinsic discount
US$11.00
Fair Value
Price US$9.66
AnalystLowTarget US$11.00
AnalystConsensusTarget US$13.02
AnalystHighTarget US$18.00

AHCO Community Narratives

·
Fair Value US$11 12.2% undervalued intrinsic discount

CMS Pressure Will Crimp Home Healthcare Yet Tech Aids Recovery

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
·
Fair Value US$13.13 26.4% undervalued intrinsic discount

Capitated Deal And AI Automation Will Transform Home Healthcare

0users have liked this narrative
0users have commented on this narrative
6users have followed this narrative
·
Fair Value US$18 46.3% undervalued intrinsic discount

Aging Population And Remote Monitoring Will Expand Home Healthcare

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
US$18
46.3% undervalued intrinsic discount
Profit Margin
5.93%
Future PE
12.84x
Price in 2029
US$23.11

Trending Discussion

Updated Narratives

AHCO logo

AHCO: Tuck In Acquisitions And Refinancing Will Shape Future Earnings Profile

Fair Value: US$11 12.2% undervalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
AHCO logo

AHCO: Capitation Contract Execution Will Support Future Cash Flow Repricing

Fair Value: US$18 46.3% undervalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
AHCO logo

Capitated Deal And AI Automation Will Transform Home Healthcare

Fair Value: US$13.13 26.4% undervalued intrinsic discount
6 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Good value with moderate growth potential.

0 Risks
2 Rewards

AdaptHealth Corp. Key Details

US$3.3b

Revenue

US$2.6b

Cost of Revenue

US$670.4m

Gross Profit

US$750.0m

Other Expenses

-US$79.6m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
-0.60
20.40%
-2.42%
120.4%
View Full Analysis

About AHCO

Founded
2012
Employees
10900
CEO
Suzanne Foster
WebsiteView website
adapthealth.com

AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States. It operates through Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home segments. The company offers sleep therapy equipment, supplies, and related services, such as continuous positive airway pressure and BiLevel services to individuals suffering from obstructive sleep apnea; oxygen and home mechanical ventilation equipment and supplies and related chronic therapy services; and medical devices, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; and other HME devices and supplies. It also provides PAP machines, wheelchairs, hospital beds, oxygen concentrators, ventilators, insulin pumps, diabetes management and wound care supplies, orthopedic bracing, breast pumps and supplies, walkers, commodes, enteral supplies, and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. was founded in 2012 and is headquartered in Conshohocken, Pennsylvania.

Recent AHCO News & Updates

Narrative Update Jun 06

AHCO: Capitation Contract Execution Will Support Future Cash Flow Repricing

Narrative Update on AdaptHealth Analysts lifted the fair value estimate for AdaptHealth stock from $17 to $18, reflecting recent price target revisions across several firms that cite updated views on the company’s outlook and valuation assumptions. Analyst Commentary Recent Street research on AdaptHealth has centered on a series of price target resets, with several bullish analysts adjusting their models and one taking a more cautious stance.
Narrative Update May 22

AHCO: Capitated Contract Investments And Legal Settlement Will Shape Future Earnings Profile

Analysts have nudged their average price target on AdaptHealth higher to about $11.00 from $9.50, reflecting updated views on valuation inputs such as a higher assumed future P/E multiple and recent mixed target changes across firms raising and lowering their dollar-based estimates. Analyst Commentary Recent Street research on AdaptHealth reflects a mix of optimism and caution, with some firms lifting price targets and others trimming them as they reassess assumptions around earnings quality, execution and balance sheet risk.

Recent updates

No updates